Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS)
CNY 2.13
(4.93%)
CNY 2.13
(4.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 285.68 Million | 681.13 Million | 192.38 Million | 119.11 Million | 265.75 Million | 552.08 Million |
| Cost of Revenue | 420.29 Million | 605.44 Million | 168.49 Million | 103.69 Million | 262.89 Million | 505.43 Million |
| Gross Profit | -134.6 Million | 75.68 Million | 23.89 Million | 15.42 Million | 2.86 Million | 46.65 Million |
| Operating Expenses | 394.45 Million | 131.28 Million | 59.52 Million | 30.44 Million | 43.83 Million | 48.74 Million |
| Selling, General and Administrative Expenses | 15 Million | 15.09 Million | 9.85 Million | 13.51 Million | 20.45 Million | 28.01 Million |
| Research and Development Expenses | 13.87 Million | 25.5 Million | 20.46 Million | 964.88 Thousand | 1.63 Million | 711.5 Thousand |
| Other Expenses | 330.75 Million | 90.67 Million | 29.2 Million | 15.96 Million | 21.74 Million | 2.36 Million |
| Cost and Expenses | 779.93 Million | 736.72 Million | 228.01 Million | 134.14 Million | 306.73 Million | 554.17 Million |
| Operating Income | -494.24 Million | -22.21 Million | 2.57 Million | 43.49 Million | -2.51 Million | 9.58 Million |
| Interest Expense | 142.61 Million | 91.87 Million | - | - | - | - |
| Income Tax Expense | -279.26 Thousand | 4.35 Million | 1.43 Million | -3.12 Million | -3.8 Million | 373.26 Thousand |
| Earnings before Tax | -516.42 Million | -165.75 Million | -28.51 Million | 20.07 Million | -55.86 Million | 11.94 Million |
| Net Income | -465.5 Million | -170.1 Million | -29.94 Million | 20.9 Million | -52.06 Million | 9.4 Million |
| Earnings Per Share Basic | -0.68 | -0.25 | -0.04 | 0.03 | -0.08 | 0.01 |
| Earnings Per Share Diluted | -0.68 | -0.25 | -0.04 | 0.03 | -0.08 | 0.01 |
| Weighted Average Shares Outstanding | 684.56 Million | 684.88 Million | 684.88 Million | 684.88 Million | 684.88 Million | 671.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 684.56 Million | 684.88 Million | 684.88 Million | 684.88 Million | 684.88 Million | 671.47 Million |
| Gross Margin | -0.47 | 0.11 | 0.12 | 0.13 | 0.01 | 0.08 |
| EBIT Margin | -0.94 | 0.15 | 0.15 | 0.49 | 0.05 | 0.10 |
| Profit Margin | -1.63 | -0.25 | -0.16 | 0.18 | -0.20 | 0.02 |
| EBITDA | -269.12 Million | 48.96 Million | -134.5 Million | 15.66 Million | 12.84 Million | 53.32 Million |
| Earnings Before Tax Margin | -1.73 | -0.03 | 0.01 | 0.37 | -0.01 | 0.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 68.87 Million | 57.55 Million | 53.89 Million | 285.68 Million | 117.07 Million | 66.62 Million |
| Cost of Revenue | 59.69 Million | 72.63 Million | 55.56 Million | 385.48 Million | 169.89 Million | 90.05 Million |
| Gross Profit | 9.17 Million | -15.07 Million | -1.66 Million | -99.79 Million | -52.81 Million | -23.43 Million |
| Operating Expenses | 31.63 Million | 61.73 Million | 16.38 Million | 67.86 Million | -11.16 Million | 18.58 Million |
| Selling, General and Administrative Expenses | 14.2 Million | 11.27 Million | 12.23 Million | - | -53.01 Million | 62.6 Million |
| Research and Development Expenses | 3.52 Million | 2.96 Million | 2.72 Million | - | 4.03 Million | 4.3 Million |
| Other Expenses | -13.9 Million | -47.49 Million | -4.33 Million | -22.22 Million | -8.79 Million | -4.44 Million |
| Cost and Expenses | 91.33 Million | 134.37 Million | 71.94 Million | 453.35 Million | 158.73 Million | 108.63 Million |
| Operating Income | -22.45 Million | -76.81 Million | -53.77 Million | -494.24 Million | -259.18 Million | -89.52 Million |
| Interest Expense | 31.11 Million | 45.77 Million | 34.74 Million | 142.52 Million | 40.54 Million | 36.86 Million |
| Income Tax Expense | 38.02 Thousand | 308.51 Thousand | -137.14 Thousand | -279.26 Thousand | 332.09 Thousand | -136.74 Thousand |
| Earnings before Tax | -58.25 Million | -382.35 Million | -58.1 Million | -516.42 Million | -267.93 Million | -93.96 Million |
| Net Income | -54.57 Million | -373.5 Million | -51.45 Million | -465.5 Million | -245.28 Million | -83.45 Million |
| Earnings Per Share Basic | -0.08 | -0.55 | -0.08 | - | -0.36 | -0.12 |
| Earnings Per Share Diluted | -0.08 | -0.55 | -0.08 | - | -0.36 | -0.12 |
| Weighted Average Shares Outstanding | 684.88 Million | 684.88 Million | 686.06 Million | 684.56 Million | 686.48 Million | 684.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 684.88 Million | 684.88 Million | 686.06 Million | 684.56 Million | 686.48 Million | 684.88 Million |
| Gross Margin | 0.13 | -0.26 | -0.03 | -0.35 | -0.45 | -0.35 |
| EBIT Margin | -0.39 | -0.80 | -0.22 | - | -0.29 | -0.65 |
| Profit Margin | -0.79 | -6.49 | -0.95 | -1.63 | -2.09 | -1.25 |
| EBITDA | -27.14 Million | -45.91 Million | -11.93 Million | - | -33.46 Million | -43.09 Million |
| Earnings Before Tax Margin | -0.33 | -1.33 | -1.00 | -1.73 | -2.21 | -1.34 |
IPCALAB
ORIENTCEM
IFBC
FIISO
1712
TLTFF